亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台，協助業界發掘知識產權貿易商機，並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權，或是製造商需要購買技術以提高操作效能，又或是知識產權配套服務供應商，你將會從本網站發掘到有用的知識產權貿易資訊。

返回搜索結果

Methods for Diagnosing and Treating Pediatric Neoplasm

總結: Lead Inventors: Anna Lasorella, MDProblem or Unmet Need:The mortality from pediatric cancers can be reduced if tumors are diagnosed and treated at an early stage. Moreover, current treatment protocols can be invasive (surgery) or can produce deleterious side-effects. Side-effects are a particular concern in pediatric neoplasms because chemotherapy and radiation can interfere with growth and thus generate serious consequences. It is clear that alternative strategies for diagnosis and treatment of pediatric neoplasms are needed in order to achieve earlier diagnosis, improve survival in children with cancer, and ease the negative effects of therapy. The Id proteins are helix-loop-helix transcription factors that have been implicated in the control of cell differentiation and cell-cycle control. Id2 mRNA is overexpressed in pancreatic cancer and certain leukemias. However, prior to this technology the role of Id2 is unclear in pediatric neoplasm. This technology discovered that Id2 is highly expressed in tumors of subjects who have neuroblastoma, and that inhibition of Id2 interrupts the Myc-Id2 transcription pathway and has an antiproliferative effect.

技術優勢: Provides early diagnosis for pediatric neoplasm Provides alternative treament for pediatric neoplasm to avoid invasive surgery and side effects caused by chemotherapy and radiation

技術應用: Diagnosis and monitoring of neuroblastomas and other pediatric neoplasms Assessing the efficacy of therapy to treat pediatric neoplasm Assessing the prognosis of pediatric neoplasm Treatment of pediatric neoplasm by inhibiting Id2 Diagnosis, monitoring, and treatment of other types of neoplasm

詳細技術說明: This technology discovered that Id2 is highly expressed in tumors of subjects who have neuroblastoma, and that inhibition of Id2 interrupts the Myc-Id2 transcription pathway and has an antiproliferative effect.

*Inquiry: Peter Golikov Columbia Technology Ventures Tel: (212) 854-8444 Email: TechTransfer@columbia.edu

*Publications: Cancer Research. 2002 Jan 1;62(1):301-6Oncogene. 2001 Dec 20;20(58):8326-33

欲了解更多信息，請點擊這裡